Jeffrey S. Levitt

Mr. Levitt is the General Counsel and Chief Compliance Officer at Stemline Therapeutics. In this role since 2018, Mr. Levitt is responsible for overseeing all aspects of legal, governance and compliance. He has led the company through two pharmaceutical product launches, public equity offerings, build-out of its global operations in the United States and Europe, and acquisition of Stemline by the Menarini Group in 2020.